期刊
STROKE
卷 44, 期 4, 页码 1080-+出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.111.000126
关键词
safety; stroke; stroke mimics; thrombolysis
资金
- Swiss National Foundation
- Kaethe-Zingg-Schwichtenberg-Fonds of the Swiss Academy of Medical Sciences
- Swiss Heart Foundation
- Swiss National Science Foundation
- AstraZeneca
- Boehringer Ingelheim
- Sanofi-Aventis
- PhotoThera
- Cardiomet-Center Hospitalier Universitaire Vaudois
- Institute of Health Research in Canada
- Lundbeck
- SHIRE Human Genetics
- BRAHMS Gesellschaft mit beschrankter Haftung
- Zorgonderzoek Nederland-Medische Wetenschappen
- Netherlands Heart Association
- Bayer
- Pfizer Inc
- Shire plc
- BrainsGate
- H. Lundbeck A/S
- Pierre-Fabre
- Actavis
Background and Purpose-Intravenous thrombolysis for acute ischemic stroke is beneficial within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating quick diagnostic in-hospital work-up. Initial time strain occasionally results in treatment of patients with an alternate diagnosis (stroke mimics). We investigated whether intravenous thrombolysis is safe in these patients. Methods-In this multicenter observational cohort study containing 5581 consecutive patients treated with intravenous thrombolysis, we determined the frequency and the clinical characteristics of stroke mimics. For safety, we compared the symptomatic intracranial hemorrhage (European Cooperative Acute Stroke Study II [ECASS-II] definition) rate of stroke mimics with ischemic strokes. Results-One hundred stroke mimics were identified, resulting in a frequency of 1.8% (95% confidence interval, 1.5-2.2). Patients with a stroke mimic were younger, more often female, and had fewer risk factors except smoking and previous stroke or transient ischemic attack. The symptomatic intracranial hemorrhage rate in stroke mimics was 1.0% (95% confidence interval, 0.0-5.0) compared with 7.9% (95% confidence interval, 7.2-8.7) in ischemic strokes. Conclusions-In experienced stroke centers, among patients treated with intravenous thrombolysis, only a few had a final diagnosis other than stroke. The complication rate in these stroke mimics was low. (Stroke. 2013;44:1080-1084.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据